Table 1 Patient, volume and treatment characteristics
Characteristic | No of patients and/or value(s) |
|---|---|
Total nr of patients | 20 |
Total EBT dose | 50Â Gy |
Total nr of EBT fractions | 25 |
Total nr of IGBT fractions | 5 |
Total IGBT dose (Mean ± SD) | 4.7 ± 0.8 Gy |
Total nr of CT datasets in study | 100 |
FIGO stage (n) | Â |
II | 5 |
III | 12 |
IVa | 3 |
Volume in cc (Mean ± SD) |  |
HR-CTV @ 1 st IGBT treatment | 49.0 ± 21.0 |
IR-CTV @ 1 st IGBT treatment | 119.0 ± 43.0 |
Rectum | 94.8 ± 32.6 |
Bladder | 108.0 ± 91.6 |
Dose objectives/constraints | Â |
HR-CTV D90 | ≥ 85 Gy |
IR-CTV D90 | ≥ 60 Gy |
Rectum D2cc | ≤ 70 Gy |
Bladder D2cc | ≤ 80 Gy |